New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) and published in Nature ...

Learn how to manage hereditary angioedema (HAE) attacks with on-demand medications, from identifying early symptoms to ...

Follow enough wellness influencers on Instagram and you’re bound to run into someone waxing poetic about peptides—or even livestreaming their injections. This buzzy practice has been popular in ...

New guidelines from two leading medical associations suggest that efforts to reduce bad cholesterol should focus on ...

AmgenAMGN reported first-quarter adjusted earnings of $5.15 per share, which beat the Zacks Consensus Estimate of $4.73 per ...

Amgen has launched a late-stage program to test the feasibility of switching patients from weekly GLP-1 injections to its own investigational obesity asset MariTide, which could open up monthly or ...

Q1 2026 Management View "We had a strong first quarter and are well positioned to achieve our objectives for the year," said (Chairman & CEO Robert Bradway), reiterating that 2026 is "a springboard ...

Repatha, a PCSK9 inhibitor, lowers cholesterol well, especially for those intolerant to statins, but its absolute risk ...

Corrections: This story was updated to clarify the findings of clinical trials and out-of-pocket cost information. As the GLP-1 weight-loss drug market continues to grow, consumers weary of needles ...

Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...

Knee osteoarthritis is a complex disease that affects the whole joint, including bone, cartilage, ligaments and muscles. Osteoarthritis is a common cause of pain and movement difficulty, affecting 8.3 ...